Regulation of T cell Differentiation

T 细胞分化的调节

基本信息

项目摘要

Project 1:Previous studies have shown that the Notch1 and TGF-β signaling pathways are mutually re-enforcing. Given recent evident that regulatory T cell (Treg) effector function is mediated by TGF-β signaling, we investigated if Notch1 signaling also participated in Treg effector function. Initial studies showed that Notch1 ligands, particularly Jagged1, is present on Tregs and that, indeed, blockade of Notch1 signaling with a anti-Jagged1 or a blocking anti-Notch1 antibody inhibits Treg suppressor function in vitro. We then showed that a signaling component generated by Notch1 activation (NICD) physically interacts with a signaling component generated by TGF-β signaling (pSmad3). Furthermore, this interaction has functional downstream effects since over-expression of NICD facilitates pSmad3 translocation to the nucleus and enhances pSmad3 transcriptional activity of a Smad sensitive promoter linked to a luciferase reporter. Finally, we showed that blockade of TGF-β signaling and Notch signaling did not have additive inhibitory effects on Treg suppressor function. These results are consistent with the conclusion that Notch1 signaling enhances and facilitates TGF-β-mediated effector function of Tregs. Project 2: Recent studies have shown that TGF-β together with IL-6 induce the differentiation of IL-17-producing T cells (Th17) T cells. We therefore examined if CD4+CD25+Foxp3+ regulatory T cells (Tregs), i.e., cells previously shown to produce TGF-β, serve as Th17 inducers. We found that upon activation purified CD25+ T cells (or sorted GFP+ T cells obtained from Foxp3-GFP knock-in mice) produce high amount of soluble TGF-β and when cultured with CD4+CD25-Foxp3- T cells in the presence of IL-6 induce the latter to differentiate into Th17 cells. Perhaps more importantly, upon activation, CD4+CD25+Foxp3+(GFP+) T cells themselves differentiate into Th17 cells in the presence of IL-6 (and in the absence of exogenous TGF-β). These results indicate that CD4+CD25+Foxp3+ regulatory T cells can function as inducers of Th17 cells and can differentiate into Th17 cells. They thus have important implications to our understanding of regulatory T cell function and their possible therapeutic use.
项目1:之前的研究表明Notch1和TGF-β信号通路是相互增强的。 鉴于最近有证据表明调节性 T 细胞 (Treg) 效应器功能是由 TGF-β 信号传导介导的,我们研究了 Notch1 信号传导是否也参与了 Treg 效应器功能。 初步研究表明,Notch1 配体,特别是 Jagged1,存在于 Tregs 上,并且事实上,用抗 Jagged1 或阻断性抗 Notch1 抗体阻断 Notch1 信号传导会在体外抑制 Treg 抑制功能。 然后我们表明,Notch1 激活 (NICD) 产生的信号传导成分与 TGF-β 信号传导 (pSmad3) 产生的信号传导成分发生物理相互作用。此外,这种相互作用具有功能性下游效应,因为 NICD 的过度表达促进 pSmad3 易位到细胞核,并增强与荧光素酶报告基因连接的 Smad 敏感启动子的 pSmad3 转录活性。 最后,我们证明阻断 TGF-β 信号和 Notch 信号不会对 Treg 抑制功能产生附加抑制作用。 这些结果与 Notch1 信号增强和促进 TGF-β 介导的 Tregs 效应功能的结论一致。 项目2:最近的研究表明,TGF-β与IL-6一起诱导产生IL-17的T细胞(Th17)T细胞的分化。因此,我们检查了 CD4+CD25+Foxp3+ 调节性 T 细胞 (Treg)(即先前显示可产生 TGF-β 的细胞)是否可充当 Th17 诱导剂。 我们发现,纯化的 CD25+ T 细胞(或从 Foxp3-GFP 敲入小鼠获得的分选的 GFP+ T 细胞)激活后会产生大量可溶性 TGF-β,并且当与 CD4+CD25-Foxp3- T 细胞在 IL-6 存在的情况下培养时,会诱导后者分化为 Th17 细胞。也许更重要的是,激活后,CD4+CD25+Foxp3+(GFP+) T 细胞本身在 IL-6 存在(且不存在外源 TGF-β)的情况下分化为 Th17 细胞。这些结果表明CD4+CD25+Foxp3+调节性T细胞可以作为Th17细胞的诱导剂,并且可以分化为Th17细胞。因此,它们对我们理解调节性 T 细胞功能及其可能的治疗用途具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WARREN STROBER其他文献

WARREN STROBER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WARREN STROBER', 18)}}的其他基金

Regulation of Immune Responses in Humans and Non-Human Primates
人类和非人类灵长类动物免疫反应的调节
  • 批准号:
    6098937
  • 财政年份:
  • 资助金额:
    $ 118.33万
  • 项目类别:
STUDIES OF PRIMARY IMMUNODEFICIENCY DISEASES
原发性免疫缺陷疾病的研究
  • 批准号:
    6160653
  • 财政年份:
  • 资助金额:
    $ 118.33万
  • 项目类别:
Regulation Of Immune Responses In Humans and in Experimental Animals
人类和实验动物免疫反应的调节
  • 批准号:
    7592151
  • 财政年份:
  • 资助金额:
    $ 118.33万
  • 项目类别:
Immunoregulatory Defects In Inflammatory Bowel Disease
炎症性肠病的免疫调节缺陷
  • 批准号:
    6674046
  • 财政年份:
  • 资助金额:
    $ 118.33万
  • 项目类别:
Immunoregulation In Humans And Non-human Primates
人类和非人类灵长类动物的免疫调节
  • 批准号:
    6985590
  • 财政年份:
  • 资助金额:
    $ 118.33万
  • 项目类别:
Regulation of T cell Differentiation
T 细胞分化的调节
  • 批准号:
    7196663
  • 财政年份:
  • 资助金额:
    $ 118.33万
  • 项目类别:
Regulation of T cell Differentiation
T 细胞分化的调节
  • 批准号:
    7732554
  • 财政年份:
  • 资助金额:
    $ 118.33万
  • 项目类别:
Regulation Of Immune Responses In Humans And Non-human P
人类和非人类免疫反应的调节
  • 批准号:
    6808163
  • 财政年份:
  • 资助金额:
    $ 118.33万
  • 项目类别:
Regulation Of Immune Responses In Humans and in Experimental Animals
人类和实验动物免疫反应的调节
  • 批准号:
    7732455
  • 财政年份:
  • 资助金额:
    $ 118.33万
  • 项目类别:
Regulation Of Immune Responses In Humans and in Experime
人类和实验中免疫反应的调节
  • 批准号:
    7299936
  • 财政年份:
  • 资助金额:
    $ 118.33万
  • 项目类别:

相似海外基金

New antiadipogenic drugs to reduce fibroadipogenic precursor cell differentiation process in DMD
新型抗脂肪形成药物可减少 DMD 中纤维脂肪形成前体细胞的分化过程
  • 批准号:
    2751293
  • 财政年份:
    2022
  • 资助金额:
    $ 118.33万
  • 项目类别:
    Studentship
Diversity Research Supplement for Combining Experiments and Computer Simulation to Improve the Stem Cell Differentiation Process
结合实验和计算机模拟改善干细胞分化过程的多样性研究补充
  • 批准号:
    10550022
  • 财政年份:
    2021
  • 资助金额:
    $ 118.33万
  • 项目类别:
Administrative Supplement for Combining Experiments and Computer Simulation to Improve the Stem Cell Differentiation Process
结合实验和计算机模拟改善干细胞分化过程的行政补充
  • 批准号:
    10606343
  • 财政年份:
    2021
  • 资助金额:
    $ 118.33万
  • 项目类别:
Inferring cell differentiation process based on phylogenetic analysis of histone modifications of human cells
基于人类细胞组蛋白修饰的系统发育分析推断细胞分化过程
  • 批准号:
    16K07458
  • 财政年份:
    2016
  • 资助金额:
    $ 118.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of Cell Differentiation Process of Entamoeba Encystation
内阿米巴包囊细胞分化过程的阐明
  • 批准号:
    16K19117
  • 财政年份:
    2016
  • 资助金额:
    $ 118.33万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Analysis of stem cell differentiation process on the basis of epigenetic change
基于表观遗传变化的干细胞分化过程分析
  • 批准号:
    25560408
  • 财政年份:
    2013
  • 资助金额:
    $ 118.33万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Histological analysis of T cell differentiation process based on hypermulticolor-hypersensitive fluorescence imaging method
基于超多色-超灵敏荧光成像方法的T细胞分化过程的组织学分析
  • 批准号:
    22590194
  • 财政年份:
    2010
  • 资助金额:
    $ 118.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Frontiers in the clarification of the muscular stem cell differentiation process involved in restoring muscle function
澄清参与恢复肌肉功能的肌肉干细胞分化过程的前沿
  • 批准号:
    19592131
  • 财政年份:
    2007
  • 资助金额:
    $ 118.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了